What BioPlan Associates does

BioPlan Associates is a privately-held market analysis and strategy consulting firm founded in 1989 and headquartered in Rockville, Maryland. The company specializes in biopharmaceutical manufacturing intelligence, serving biopharma operators, CDMOs, single-use technology suppliers, equipment manufacturers, emerging biotechs, and private equity and strategic investors across global markets with emphasis on the US, Europe, China, and India. The firm positions itself as an independent, vendor-conflict-free source of validated primary research, with products and services designed to reduce decision risk for capital commitments, market entries, product launches, and acquisitions.

The company's core intellectual property is built on 30+ years of continuous biomanufacturing benchmarking. Proprietary database products include the Top1000Bio Facility Index (tracking 1,500+ global biopharma facilities), the Top200 Cell and Gene Therapy Facilities Database, the Top300 Bio CDMO Facilities Database, and the Top100 China Biomanufacturers Database. The flagship publication is the 22nd Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production (539 pages), supplemented by topical reports on China, India, expression systems, biosimilars, and clinical trials. Underlying these assets is a 750-member Biotechnology Industry Council of global decision-makers and a bench of 77 independent consultants that enable rapid primary research.

BioPlan generates revenue through four streams: (1) strategic advisory and consulting engagements (M&A due diligence, market entry strategy, technology adoption modeling, competitive threat assessment) delivered on a project basis; (2) annual and topical market research reports sold as digital PDFs and hardcover editions with global license options; (3) recurring subscriptions to proprietary databases with quarterly newsletters and analyst access; and (4) one-time book and publication sales. Pricing is not publicly disclosed; all products are sold via direct contact with sales. The firm has remained independently held without external funding since founding, operating as a bootstrapped consulting and research firm for over three decades.

Name

BioPlan Associates

Legal name

BioPlan Associates, Inc.

Website

https://bioplanassociates.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

1–10 employees

Short description

BioPlan Associates is a privately-held, independent biopharmaceutical market intelligence and strategy consulting firm founded in 1989, serving CDMOs, bioprocessing suppliers, pharma companies, and PE investors with proprietary facility databases, annual benchmark reports, and bespoke advisory engagements.

Ownership category

akta.pro rank

Headquarters

HQ city

Rockville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Strategic Advisory & Consulting: Custom consulting engagements for M&A due diligence, market entry strategy, technology adoption modeling, and competitive threat assessment. Revenue generated through project-based professional services engagements with biopharma operators, investors, and CDMO leaders.
2. Market Research Reports: Annual and topical reports including the flagship 22nd Annual Report of Biopharmaceutical Manufacturing Capacity and Production (539 pages). Reports available as digital PDFs and hardcover editions with global license options.
3. Database Subscriptions: Subscription-based access to Top1000Bio, Top200 Cell and Gene Therapy Facilities, Top300 CDMO Facilities, and regional databases (China Top 100, India Top 60). Includes quarterly newsletters and analyst access.
4. Publications & Books: Sale of specialized books covering biopharmaceutical technology in China, India, expression systems, clinical trials guides, and market directories.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

BioPlan Associates delivers strategic market intelligence and consulting services to the global biopharmaceutical industry through proprietary facility tracking databases, annual benchmarking reports, and custom research/advisory engagements. Their databases cover over 1,500 biopharma facilities, 400+ CDMO facilities, and 200+ cell/gene therapy facilities globally. Their flagship 22nd Annual Biomanufacturing Report is the longest-running industry benchmark study, supported by a 750-member Biotechnology Industry Council for primary research.

Product overview

BioPlan Associates is a consulting firm offering a portfolio of market intelligence products including specialized databases and advisory services. The core database products include the Top1000Bio Facility Index (tracking 1,500+ global biopharma facilities), Top200 Cell and Gene Therapy Facilities Database (200+ facilities), Top300 Bio CDMO Facilities Database (400+ contract manufacturing facilities), and Top100 China Biomanufacturers Database. These are complemented by flagship publications including the Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production (539 pages), the Advances in Biopharmaceutical Technology in China report, the Growth of Biopharmaceutical Contract Manufacturing Organizations in China study, China Top Biopharmaceutical Manufacturing Directory, Top 60 Distributors of Bioprocessing Supplies in China, India Top 60 Biopharmaceutical Manufacturers Directory, Biopharmaceutical Expression Systems reference, Quick Guide to Clinical Trials, and Quick Guide to Healthcare and Biotechnology in the Middle East. Advisory services include custom market research (market sizing, forecasting, new product development, technology evaluation, pricing analysis, voice of customer) and strategic advisory consulting (M&A due diligence, market entry strategy, tech adoption modeling). The company also operates the Biotechnology Industry Council, a 750-member global decision-maker panel network.

Differentiator

Problem solved

Functional benefit

Products and services

• Top1000Bio Facility Index and Database Global biofacilities index and database subscription tracking over 1,500+ facilities worldwide manufacturing biopharmaceuticals, based on 30 years of industry evaluation and benchmarking. Used by biopharma operators and investors for facility-level competitive and market intelligence.
• Top200 Cell and Gene Therapy Facilities Database Global cell and gene therapy facilities database actively tracking over 200+ dedicated facilities providing cell therapy and gene therapy development and manufacturing services for biopharmaceuticals.
• Top300 Bio CDMO Facilities Database Comprehensive database of contract manufacturing tracking over 400+ bioprocessing facilities providing contract manufacturing services for biopharmaceuticals. Used by CDMOs and biopharma sponsors for capacity benchmarking and partnership identification.
• Top100 China Biomanufacturers Database Comprehensive database of China's rapidly growing bioprocessing facilities, capacities, staffing, management, objectives, and market data. Designed for companies seeking to enter or expand in the Chinese biopharma market.
• Biopharmaceuticals in the US and European Markets Database Encyclopedic monographs database covering all biopharmaceutical products including recombinant proteins, monoclonal antibodies, vaccines, enzymes, blood products, radioimmune conjugates, cultured cells and tissues. Authored by Ronald A. Rader.
• Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production Longest-running comprehensive study of bioprocessing professionals providing 539 pages of data-rich analysis on capacity, production trends, benchmarks, and industry outlook. The 22nd edition (2025) surveyed 203 companies, 116 vendors, and 21 countries. Available as digital PDF (Single-Office and Global License) and hardcover editions.
• Advances in Biopharmaceutical Technology in China Peer-reviewed study incorporating research from over 100 global industry expert authors covering biopharmaceutical technology developments in China.
• Growth of Biopharmaceutical Contract Manufacturing Organizations in China Comprehensive in-depth study providing detailed analysis of China's CMO industry, recent development, and trends, including profiles of CDMOs with capacity, history, products, and business strategies.
• China Top Biopharmaceutical Manufacturing Directory Directory of major biopharmaceutical manufacturing facilities in China covering facilities with the most bioprocessing capacity, including company ownership, management, capacity, and products.
• Top 60 Distributors of Bioprocessing Supplies in China Comprehensive directory providing detailed profiles of China's equipment and supply distributors industry with competitive landscape analysis.
• Directory of Top 60 Biopharmaceutical Manufacturers in India Directory with detailed profiles of Indian biopharmaceutical companies covering business focus, products, revenues, R&D, and international objectives.
• Biopharmaceutical Expression Systems Reference covering new expression systems and improvements for commercial-scale manufacture of biopharmaceutical products, including platform technologies, prokaryotes, yeasts, mammals, and mammalian cell systems. Authored by Ronald A. Rader.
• Quick Guide to Clinical Trials Textbook resource covering clinical trial processes and drug development from an international perspective with 18 chapters written by industry experts.
• Quick Guide to Healthcare and Biotechnology in the Middle East Reference covering the Middle East regional pharmaceutical market valued at approximately US$10.6 billion, including healthcare industry investments and biotech opportunities.
• Custom Market Research Primary-source intelligence including market sizing and forecasting, new product development, new technology evaluation, pricing and value quantification, and voice of customer research. Engagements conducted directly with biopharma operators, investors, and CDMO leaders.
• Strategic Advisory & Consulting Advisory services supporting M&A committees, market-entry steering groups, and platform-investment decisions including due diligence, market entry strategy, and tech adoption modeling. Project-based engagements with biopharma operators, investors, and CDMO leaders.
• Biotechnology Industry Council 750-member global decision-maker panel providing access to industry expertise and independent consultant bench for conducting research studies. Core differentiator enabling rapid primary research fielding for consulting engagements.

Quantifiable outcome

• Decision-risk reduction for high-stakes biopharma moves including capital commitments, market entries, product launches, and acquisitions
• +2 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles7 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Biotechnology Industry CouncilcoreOthersStanding panel of 750+ global decision-makers enabling primary research capabilities. Independent consultants and experts bench that allows rapid study fielding. Key differentiator for primary market intelligence gathering.

Scale indicators9 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• MarketsandMarkets: Market research and consulting firm with significant pharma/biotech practice covering bioprocessing, CDMOs, and biosimilars. Competes in syndicated market intelligence and strategic advisory across biopharma segments served by BioPlan.
• Roots Analysis: Specialized market research firm focused on pharma, biotech, and healthcare markets with syndicated reports on biopharma manufacturing, cell therapy, and emerging modalities. Closely comparable to BioPlan's report-style offerings in scope and customer type.
• PharmaCircle: Pharmaceutical product and business intelligence platform with proprietary databases on drugs, companies, and excipients. Comparable to BioPlan's biopharma intelligence database business, serving overlapping buyer personas in biopharma strategy and competitive intelligence.
• GlobalData: Data and analytics company with extensive pharma/biopharma practice including proprietary databases, syndicated reports, and consulting. Competes across BioPlan's full service portfolio from facility intelligence to strategic advisory.
• Frost & Sullivan: Global market intelligence and consulting firm with a deep life sciences practice covering biopharma manufacturing, CDMOs, and emerging modalities. Competes in syndicated pharma market research and strategic advisory engagements.
• Citeline: Biopharma intelligence platform from Informa providing databases, analytics, and reports across drug development, clinical trials, and commercialization. Directly competes with BioPlan's biopharma market intelligence offerings across syndicated research and advisory services.
• Mordor Intelligence: Market research firm covering pharma, biotech, and healthcare industries with syndicated reports and consulting. Overlaps directly with BioPlan's report and advisory offerings in biopharma market sizing and competitive analysis.
• Evaluate: Pharma industry analysis platform offering consensus forecasts, deal intelligence, and company analysis for biopharmaceuticals. Overlaps with BioPlan's market sizing, competitive intelligence, and M&A due diligence services.

Broad incumbents

• IQVIA: Massive life sciences analytics and services platform with broad portfolio of biopharma intelligence, R&D services, and commercial solutions. Overlaps with BioPlan's market intelligence while operating at much greater scale across the pharma value chain.
• Clarivate: Scientific and IP intelligence company offering Cortellis for biopharma drug, clinical trial, and patent intelligence. Broad incumbent with biopharma specialization overlapping BioPlan's domain of decision-support intelligence.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/bioplaninc

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioPlan Associates